Search research articles
Contact Us
Filters
Showing results (41-50 of 79) with videos related to
Page
of 8
Sort By:
The Lancet. Haematology
|
March 26, 2021
Quality of control groups in randomised trials of multiple myeloma enrolling in the USA: a systematic review
Ghulam Rehman Mohyuddin, Kelly Koehn, Douglas Sborov, et al.
JCO Precision Oncology
|
July 7, 2017
Next Generation Sequencing Reveals Potentially Actionable Alterations in the Majority of Patients with Lymphoid Malignancies
Aaron M Goodman, Michael Choi, Matthew Wieduwilt, et al.
Cancers
|
September 28, 2023
Outcomes of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Large B-Cell Lymphoma (LBCL): A Single-Institution Experience
Aaron Trando, Anna Ter-Zakarian, Phillip Yeung, et al.
EJNMMI Research
|
December 9, 2020
Relationship between tumor mutational burden and maximum standardized uptake value in 2-[<sup>18</sup>F]FDG PET (positron emission tomography) scan in cancer patients
Amin Haghighat Jahromi, Donald A Barkauskas, Matthew Zabel, et al.
Journal of Cancer Policy
|
February 11, 2023
Quality of content reporting on two major oncology media websites: OncLive and Targeted Oncology
Naman Sharma, Cole Wayant, Karun Neupane, et al.
Therapeutic Advances in Medical Oncology
|
September 2, 2024
Higher tumor mutational burden and PD-L1 expression correlate with shorter survival in hematologic malignancies
Ah-Reum Jeong, Aaron H Trando, Sean D Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2017
Hypermutated Circulating Tumor DNA: Correlation with Response to Checkpoint Inhibitor-Based Immunotherapy
Yulian Khagi, Aaron M Goodman, Gregory A Daniels, et al.
Oncoimmunology
|
February 6, 2018
Genomic landscape of advanced basal cell carcinoma: Implications for precision treatment with targeted and immune therapies
Aaron M Goodman, Shumei Kato, Philip R Cohen, et al.
Journal of Cutaneous Pathology
|
December 14, 2020
Cutaneous intralymphatic anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma arising in a patient with multiple rounds of breast implants
Huan-You Wang, John A Thorson, Brian R Hinds, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 3, 2022
Characteristics of clinical trials for haematological malignancies from 2015 to 2020: A systematic review
William Wesson, Vincent L Galate, Douglas W Sborov, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 79) with videos related to
Sort By:
Page
of 8
The Lancet. Haematology
|
March 26, 2021
Quality of control groups in randomised trials of multiple myeloma enrolling in the USA: a systematic review
Ghulam Rehman Mohyuddin, Kelly Koehn, Douglas Sborov, et al.
JCO Precision Oncology
|
July 7, 2017
Next Generation Sequencing Reveals Potentially Actionable Alterations in the Majority of Patients with Lymphoid Malignancies
Aaron M Goodman, Michael Choi, Matthew Wieduwilt, et al.
Cancers
|
September 28, 2023
Outcomes of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Large B-Cell Lymphoma (LBCL): A Single-Institution Experience
Aaron Trando, Anna Ter-Zakarian, Phillip Yeung, et al.
EJNMMI Research
|
December 9, 2020
Relationship between tumor mutational burden and maximum standardized uptake value in 2-[<sup>18</sup>F]FDG PET (positron emission tomography) scan in cancer patients
Amin Haghighat Jahromi, Donald A Barkauskas, Matthew Zabel, et al.
Journal of Cancer Policy
|
February 11, 2023
Quality of content reporting on two major oncology media websites: OncLive and Targeted Oncology
Naman Sharma, Cole Wayant, Karun Neupane, et al.
Therapeutic Advances in Medical Oncology
|
September 2, 2024
Higher tumor mutational burden and PD-L1 expression correlate with shorter survival in hematologic malignancies
Ah-Reum Jeong, Aaron H Trando, Sean D Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2017
Hypermutated Circulating Tumor DNA: Correlation with Response to Checkpoint Inhibitor-Based Immunotherapy
Yulian Khagi, Aaron M Goodman, Gregory A Daniels, et al.
Oncoimmunology
|
February 6, 2018
Genomic landscape of advanced basal cell carcinoma: Implications for precision treatment with targeted and immune therapies
Aaron M Goodman, Shumei Kato, Philip R Cohen, et al.
Journal of Cutaneous Pathology
|
December 14, 2020
Cutaneous intralymphatic anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma arising in a patient with multiple rounds of breast implants
Huan-You Wang, John A Thorson, Brian R Hinds, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 3, 2022
Characteristics of clinical trials for haematological malignancies from 2015 to 2020: A systematic review
William Wesson, Vincent L Galate, Douglas W Sborov, et al.
Page
of 8